Clesacostat, AcetylCoACarboxylase, AcetylCoA Carboxylase, ACC, NSC170984, NSC-170984, NSC 170984, STAT5 Inhibitor III, R 6238,, PF 05221304, PF05221304, PF-05221304
PF-05221304 (NSC-170984) is an orally bioavailable, liver-directed inhibitor of acetyl-CoA carboxylase (ACC), a key enzyme regulating de novo lipogenesis. This small molecule is utilized in research to investigate metabolic diseases, including non-alcoholic steatohepatitis (NASH), in both cellular and animal models.